Therapsil CEO Spencer Hawkswell Speaks To Health Canada’s Intent To Deny Section 56 Exemptions To Healthcare… Feb 9, 2022
Entheon Biomedical: Could DMT Be A Superior Psychedelic Treatment For Substance Use Disorder? Feb 4, 2022
